ANXA1 and familial pancreatic carcinoma: Notably, high ANXA1 expression was significantly associated with worse overall survival in the TCGA PDAC cohort (Supplementary Fig. 4h), further supporting its potential role as a prognostic biomarker in pancreatic cancer.